Connect with us

Cannabis News

New GCNC and Whitney Economics report examines Europe’s expanding role in global cannabis markets

Published

on

Europe’s cannabis economy has long been described as a sleeping giant. A new international report suggests that Europe’s sleeping giant is finally waking up.

Released this week at the Cannabis Europe 2026 conference in London, a new report by the Global Cannabis Network Collective (GCNC), in partnership with Whitney Economics, examines how medical cannabis expansion, international trade, pharmaceutical production standards and evolving frameworks make the EU and UK one of the closest regions to the cannabis industry.

report, What you need to know: EU and UK Cannabis Market UpdateIt combines quantitative analysis from Whitney Economics with insights from operators, lawyers, consultants, patient advocates and market leaders in Europe and the UK.

The findings suggest that the European cannabis market is entering a critical period of transition as access to medicine programs expand, telemedicine accelerates patient adoption, EU GMP standards reshape supply chains and countries in the region continue to develop different regulatory frameworks.

“Europe is taking a much more methodical and medical approach to cannabis reform than many markets have achieved in previous expansion cycles,” said Beau Whitney, chief economist at Whitney Economics and lead author of the report. “This slow pace may frustrate some operators, but it is also creating a structure, predictability and long-term institutional credibility that is attracting increasing international attention.”

According to the report, Europe is the largest secondary market for cannabis globally, by value, despite being fragmented across many national regulatory systems. At the same time, healthcare access programs, telemedicine platforms and international supply chains are rapidly developing in the region.

Among the report’s key findings, Germany continues to set the pace for cannabis reform in Europe, even as growing imports and price pressures begin to reshape the economics of the market. The UK cannabis market is expanding rapidly through private clinics and telemedicine, despite barriers linked to doctor education, affordability, stigma and NHS involvement. The international trade in cannabis to Europe continues to accelerate, with imports from Canada, Portugal, Latin America, Africa, Australia and other emerging supply regions. EU GMP standards are increasingly becoming a defining factor in European cannabis markets seeking long-term participation. Industry observers believe the next three to five years will be a defining period for both policy reform and market growth in Europe and the UK.

“Europe is no longer just reacting to cannabis reform,” said Jillian Reddish, founder of the GCNC. “The region is increasingly helping to shape what the next phase of the global cannabis industry looks like, from international trade standards and access to medicine models to pharmaceutical manufacturing expectations and long-term market infrastructure.”

The report includes regional market insights and commentary from contributors in Germany, Portugal, Spain, the Czech Republic and the UK, highlighting emerging opportunities and operational complexities across the region. Topics include Germany’s rapidly evolving telemedicine ecosystem, Portugal’s growing role as a cultivation and processing hub, Spain’s medical access reforms, and the Czech Republic’s emerging and evolving cannabis policy.

The report also highlights that price compression, already visible in mature cannabis markets globally, is beginning to emerge in Europe as imports increase, supply chains mature and competitive pressures intensify. Germany in particular is showing early signs of falling wholesale and retail prices linked to rising imports and inventories.

For operators, investors and policy makers, the report highlights the importance of understanding market share, regulatory risk, supply demand dynamics and long-term positioning as the European cannabis economy continues to evolve.

Over the years, cannabis has been established from a perspective of disruption and unlimited highs. But as international markets mature, the report suggests the industry is increasingly being shaped by the same forces that affect other global products: trade routes, logistics, manufacturing standards, supply economics and price competition. As markets evolve, long-term success will depend not only on demand, but also on operational efficiency, regulatory compliance and the ability to compete in an increasingly interconnected global marketplace.

For more information:
Whitney Economics
Beau Whitney
(503) 724-3084
www.whitneyeconomics.com

Cannabis News

We don’t really deal with a lot of mites because of our IPM program

Published

on

By

Flora Farms Pest Management Program it is built to reduce to nothing depending on the harvestso the plant ends up clean. Luke Allenbrand, Flora Farms’ crop leader, leads an integrated pest management program that focuses on prevention. “We don’t honestly deal with a lot of mites because of the IPM program, because of the predatory mites that we’ve put down as a precaution,” says Luke. “It allows us to have a much cleaner garden in the back half.” Preventative work keeps spray volumes relatively low because the curative side of the program rarely needs to be heavy.

“Actually, we are at the lowest number of these sprays that we have. The milliliters that we are using are numbers that do not exist to be a prevention,” says Luke. “But as soon as you see an uptick of those mites or anything, we bring it up to a therapeutic amount, which is still a small milliliter. And as long as you’re on a fast track with it, you see them disappear within 10 days.” The targets are spider mites, which feed on the plant’s THC and terpene production and degrade the flower.

© Flora Farms

Tested solutions
The three products used by the company are derived from agricultural and food use. “We actually apply about three insecticides that are very common around the agricultural and food grade of these products, using a suite of IPM, Venerate and Grandevo, insecticides that will deal with these mites,” says Luke. The application is intermittent rather than constant. “We usually use a 5-day spray cycle so we can have rest periods in between, so it’s not just a consistent density of that spray,” says Luke. He sees progress against mites in the gaps between the successions.

However, at some point, the spraying stops. “We finish the spray cycle by day 40. We usually don’t want to spray anywhere after day 40. At that point, you’re going to damage the product,” says Luke. “And at that point, we’ll put predatory mites in. It really helps us get to that final push point by day 59, 60 of that harvest. So we actually have a lot less of our spray in that late period. So it’s a much better tasting product.” Predatory mites take over the job of spraying, leaving nothing on the flower.

Biological control
Biological control has two forms. “We usually use them, they’re called crazy mites, and honestly, it’s crazy to see,” says Luke. “Actually, I’ve seen some of the ones in a close-up photo kill a bug, some of the cocoons actually drive away, and even attack the spider mites themselves. Very beneficial. Callias are also slow. They’re little bags that we hang on plants and they’re very beneficial to us.” Different predators work at different speeds, which is why the program runs more than one.

Missouri’s testing regime is the context in which growers operate. Each plant is tested for pest control chemicals and must pass before the product goes ahead. “Other crops and other black market shops or smoke shops in Missouri don’t have to worry about the testing we have to do,” Luke says. “Everything we use here is natural. Each of our pest management is a lot of essential oils that fight these mites. Everything we would put on a plant is food grade.” The test covers foreign chemicals, heavy metals, and anything else that an unregulated supply should never consider.

The whole arc is from biology to chemistry and back to biology. “We go from predatory mites to a food-grade spray regimen, and then back to predatory mites at the end. That way, these plants will have time to finish with no chemicals, nothing,” says Luke. “The rest of that life cycle, about 15 to 20 days, is the most natural it will have. No spraying at all during that, just to push predatory mites off that end, so there’s no residual mite damage on those plants.”

For more information:
Flower Farms
florafarmsmo.com

Continue Reading

Cannabis News

California Bill To Legalize Marijuana Dispensary Drive-Thru Windows Advances In Senate After Clearing Full Assembly

Published

on

By

It has been passed by a California Senate committee and passed by the Assembly bill that would allow marijuana dealers to offer car windows to serve customers.

The measure, which cleared the Senate Business, Careers and Economic Development Committee on a 7-3 vote Monday, says licensed cannabis retailers and micro-businesses with storefronts can sell marijuana products “in a motor vehicle to a customer in a drive-through located on the premises.”

Under Assemblywoman Gail Peller’s (D) AB 2697, cannabis businesses would need permission from the local jurisdictions in which they operate to add a drive-thru.

The sponsor told committee members before the final vote that the bill will “expand access to legal cannabis products while strengthening our ability to compete with the illegal market.”

Annie Aubrey of Chuck’s Wellness Center, a retailer in Placerville, testified that the legislation is “about improving access.”

“A large portion of our customers use cannabis as medicine, including seniors, veterans and people living with chronic conditions that affect mobility, the population that this regulated system seeks to serve,” he said. “For many, even simple tasks like getting out of a vehicle or navigating a retail space can be physically difficult or prohibitive…A drive-thru option removes that barrier, giving patients and consumers access to what they need in a way that’s dignified and consistent with their healthcare needs.”

Amy O’Gorman Jenkins of the California Cannabis Operators Association said the legislation will provide “operational flexibility” in a highly regulated system.

“It doesn’t expand who can access cannabis,” he said. “It allows retailers, with local approval, to serve existing patients and customers more efficiently.”

Jenkins also argued that this measure could improve security.

“Currently, road traction transactions are already allowed. This means that workers regularly have to leave a safe premises while transporting the product, and sometimes they have to deposit cash in parking lots,” he said. “AB 2697 provides an additional mechanism for obtaining product, but requires a fixed and secure transaction point, keeping employees inside and reducing exposure to theft.”

Pellerin, the bill’s sponsor, previously said that “California cannabis retailers lack a common and accessible transaction channel for consumers that so many other retailers in California offer, including fast food, pharmacies, banks and even liquor stores.”

“Cannabis consumers with mobility issues or other disabilities have limited options for obtaining cannabis without having to get out of their vehicles. And while home delivery is legal, there are restrictions on service areas,” he said. “Allowing cannabis sellers to add a secure ride option, if allowed by their local jurisdiction, will improve the consumer experience, increase the security of cannabis sellers and help expand California’s legal cannabis market.”

The California Association of Narcotics Officers opposes the proposal, however, as a representative, Ryan Sherman, testified that it would make it more difficult for dispensary workers to check the IDs of customers who are of legal age or to spot signs of current intoxication at drive-thru windows.

“This bill prioritizes speed of sale over public safety while undermining existing protections designed to prevent illegal sales and protect public safety,” he argued.

Under current policy during the COVID pandemic, dispensaries can already offer street pickup.

The invoice that moving forward in the legislature would mandate that auto sales “be made through a fixed panel security window with a security drawer or similar secure transfer mechanism that is part of a building located within the premises.”


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

California regulators recently approved emergency rule changes to the state’s marijuana licensing process. to make it easier for companies to receive benefits In line with the Trump administration’s latest move to federally regulate medical cannabis.

While Gov. Gavin Newsom (D) recently He took credit for helping lead the state’s push to legalize marijuana and discussed his limited experience with cannabis use.

In October, however, Newsom vetoed a bill that would have It allowed micro-marijuana companies to ship medicinal cannabis directly to patients Through common carriers like FedEx and UPS, he said the proposal would be “too burdensome and complex to manage.”

Newsom signed a bill earlier this month streamlining research into marijuana and psychedelics.

In September, the governor also signed a measure pause on the recent tax increase on marijuana products.

Separately, the state attorney general says Indian tribes cannot independently participate in the marijuana trade with licensed cannabis businesses without obtaining their own commercial license from state officials.

California officials have recently been rewarded nearly $30 million in grants for marijuana-focused academic research projects.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Concert Series Specials launched for state medical cannabis patients

Published

on

By











Post Dispensary, Kentucky’s first medical cannabis dispensary, is connecting with patients in Owensboro, Henderson, Bowling Green, Elizabethtown, Madisonville, Hopkinsville and surrounding areas by aligning unique specials with the region’s summer concert calendar. Located at 300 N Main St. in Beaver Dam, minutes from major highways connecting these vibrant cities.

This summer, The Post Dispensary is offering special pricing and incentives for Concert Series Events at the Beaver Dam Amphitheater, SPARKS in the Park 4th of July celebration and surrounding events, such as Owensboro’s ROMP Festival (June 24-27, 2026). Patients can stop by before or after shows for big savings.

“We’re more than just a booty,” said a dispensary representative. “From Owensboro’s world-class ROMP Festival to Beaver Dam’s Amphitheater events, we’re making it convenient and budget-friendly for patients in Owensboro, Henderson, Bowling Green, Elizabethtown, Hartford and beyond to combine our love of music with compassionate care and an affordable product.”

The Post Dispensary hosts regular Patient Guidance events on the second Saturday of every month. These units have professionals on hand to assess patients and issue written certificates at low cost, application support and expert consultations in a welcoming environment. The next Patient Drive aligns perfectly with summer travel patterns, making it easy for patients from Owensboro, Bowling Green, Elizabethtown, Madisonville, Henderson, Madisonville and surrounding towns to plan a trip to Beaver Dam that combines care with community and entertainment.

For more information:
Post-Dispensary
thepostdispensary.com/










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media